ERBB2 and neoplasm: The mean tumor size was 30 mm and 50% of carriers displayed a triple negative breast cancer (TNBC) phenotype with two additional cases harboring negative hormone receptors with unknown human epidermal growth factor receptor 2 (HER2) status.